Parenteral Nutrition Market - Forecast (2022 - 2027)
According to Crohn’s & Colitis UK, around 300,000 people suffer from crohn’s disease and ulcerative colitis in the UK annually.[1] Malnourishment is the common cause of inflammatory bowel disease (IBD) among a large section of people in both under-developed and developing countries. On a larger perspective, total parenteral nutrition (TPN) serves as a primary treatment for IBD by restoring the nutritional deficiency caused due to resultant intestinal failure. Parenteral nutrition therapy is gaining wide recognition in the medical sector since it is helpful in treating gastrointestinal disorders and cancer. The global parenteral nutrition market is experiencing a demand upsurge owing to the rising malnourished population. The global parenteral nutrition market generated $4.3 billion in revenue in 2018. Growing awareness programs initiated both by the governmental and private organizations have increased knowledge about chronic diseases among the mass, thereby escalating the parent...